Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2020-03-13 Declaration of Voting R…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed, including financial statement approval, director appointments, and remuneration limits. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the official outcomes of shareholder votes at the AGM.
2020-03-13 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the appointment of new outside directors (Cho Hyun-chan and Lee Jung-il) for the company SLS Bio. This falls under the category of board management and changes in corporate governance structure, which is classified as MANG (Board/Management Information).
2020-03-13 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for SLS Bio. It contains the meeting agenda, details on voting, and management information (such as director activities and financial statements) to be presented to shareholders. This type of document is standard for proxy solicitation and shareholder meeting materials, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-05 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from SLS Bio. It provides a summary of the audit opinion, key financial data (assets, liabilities, profit/loss), and the name of the accounting firm. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report to the exchange, rather than the full annual report document itself. Therefore, it is classified as an Audit Report/Information filing. FY 2019
2020-03-05 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for SLS Bio. It outlines the date, location, and specific agenda items (such as approval of financial statements, election of directors, and remuneration limits). This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2020-02-27 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for SLS Bio. It contains the meeting agenda, details on voting rights, and management's reference materials (business overview, financial statements, and board activity reports) required for shareholders to make informed decisions at the upcoming AGM. This aligns with the definition of Proxy Solicitation & Information Statement (PSI) materials, which are provided to shareholders to request votes and provide necessary meeting information.
2020-02-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.